These FAQs outline key recommendations and practical takeaways from the AUA/SUFU/AUGS Genitourinary Syndrome of Menopause guideline.
|Articles|February 1, 2002
Varicocelectomy found more cost effective than ART
Orlando, FL-Is assisted reproduction technology (ART) a better way to deal with varicocele-related infertility, or is surgical repair the better choice? Given the high pregnancy success of ART, the optimal management of infertility secondary to varicocele is unclear," said Paul J. Turek, MD, associate professor of urology, University of California, San Francisco.
Advertisement
Advertisement
Related to this article
Heather Florio joins to discuss the potential role of supplements in pelvic and sexual health.
Long-term QUILT-3.032 findings show durable responses with Anktiva plus BCG in BCG-unresponsive NMIBC, with an estimated 84.2% cystectomy-free survival at 3 years.
Vignesh Packiam, MD, discusses strategies to manage intravesical therapy toxicity in NMIBC, improve treatment tolerability, and preserve bladder function.
Sandip M. Prasad, MD, MPhil, discusses the safety profile of mitomycin intravesical solution, including common adverse events and patient counseling during chemoablation for NMIBC.
Sandip M. Prasad, MD, MPhil, discusses 3-year ENVISION trial data showing durable responses with mitomycin intravesical solution for recurrent LG-IR-NMIBC.
Armine K. Smith, MD, discusses sexual health counseling, sex-specific considerations, and organ-preserving approaches for patients undergoing radical cystectomy.
This approval expands the label for nogapendekin alfa inbakicept to include patients with high-grade papillary-only tumors.
Advertisement
Advertisement
Trending on Urology Times
1
Matching mCSPC treatment to the patient, not just the trial data
2
Anktiva plus BCG shows durable responses in BCG-unresponsive NMIBC
3
Urocross Expander System enters US commercial use for symptomatic BPH
4
Butterfly Prostatic Retraction Device granted EU MDR certification for BPH
5